Initial Clinical Experience With Gemcitabine, Cisplatin, and Nivolumab for Advanced Urothelial Carcinoma: A Four-case Series
In Vivo · 2026-11 · 40 (6) · 3912-3921
DOI: 10.21873/invivo.14528 ↗Kurz gefasst
Fallbericht in der Zeitschrift In Vivo, online erschienen am 29.10.2026. Verfasst von Shuji Tsubota und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka, Japan. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka, Japan.
- Department of Uro-Oncology, Saitama Medical University International Medical Center, Hidaka, Japan gk3281@5931.saitama-med.ac.jp.
Zitieren
APA
Tsubota, S., Kaneko, G. O., Igarashi, D., Takahashi, T., Baba, Y., & Shirotake, S. (2026). Initial Clinical Experience With Gemcitabine, Cisplatin, and Nivolumab for Advanced Urothelial Carcinoma: A Four-case Series. In Vivo, 40(6), 3912-3921. https://doi.org/10.21873/invivo.14528
Vancouver
Tsubota S, Kaneko GO, Igarashi D, Takahashi T, Baba Y, Shirotake S. Initial Clinical Experience With Gemcitabine, Cisplatin, and Nivolumab for Advanced Urothelial Carcinoma: A Four-case Series. In Vivo. 2026;40(6):3912-3921. doi:10.21873/invivo.14528
BibTeX
@article{Tsubota2026,
author = {Tsubota, Shuji and Kaneko, G O and Igarashi, Daisuke and Takahashi, Takayuki and Baba, Yuto and Shirotake, Suguru},
title = {Initial Clinical Experience With Gemcitabine, Cisplatin, and Nivolumab for Advanced Urothelial Carcinoma: A Four-case Series},
journal = {In Vivo},
year = {2026},
volume = {40},
number = {6},
pages = {3912--3921},
doi = {10.21873/invivo.14528}
}
EUVIMED